Cite
Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
MLA
Zhao, Qian, et al. “Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.” PLoS ONE, vol. 11, no. 3, Mar. 2016, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0150419.
APA
Zhao, Q., Qin, Q., Sun, J., Han, D., Wang, Z., Teng, J., & Li, B. (2016). Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis. PLoS ONE, 11(3), 1–12. https://doi.org/10.1371/journal.pone.0150419
Chicago
Zhao, Qian, Qin Qin, Jinglong Sun, Dan Han, Zhongtang Wang, Junjie Teng, and Baosheng Li. 2016. “Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.” PLoS ONE 11 (3): 1–12. doi:10.1371/journal.pone.0150419.